Refractory Acute Lymphoblastic Leukemia (ALL)

Explore clinical trials studying Refractory Acute Lymphoblastic Leukemia (ALL). Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Refractory Acute Lymphoblastic Leukemia (ALL) trial results

Recruiting

NCT06287528

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Cancer Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States

Active, Not Recruiting

NCT02091245

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia (CML) in Blast Crisis, +26 more
Locations: UCSF San Francisco, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

Children's Healthcare of Atlanta Atlanta, Georgia, United States

Boston Children's Hospital Boston, Massachusetts, United States